Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Silco Pharmaceuticals Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 16, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Market Capitalization	1,526	1,754	2,533	2,741	2,709	2,325
Market Cap Growth	-15.19%	-30.74%	-7.58%	1.15%	16.52%	0.16%
Enterprise Value	1,506	1,703	2,491	2,643	2,599	2,064
Last Close Price	14.70	16.80	23.94	25.35	24.10	19.78
PE Ratio	29.39	38.24	36.59	32.45	32.01	27.96
PS Ratio	3.61	4.28	5.45	4.90	4.51	3.17
PB Ratio	0.64	0.75	1.09	1.20	1.20	1.03
P/TBV Ratio	0.64	0.75	1.09	1.20	1.20	1.03
P/FCF Ratio	-	32375.63	-	43.53	-	-
P/OCF Ratio	16.57	20.81	14.03	16.21	10.53	15.86
EV/Sales Ratio	3.56	4.15	5.36	4.72	4.32	2.81
EV/EBITDA Ratio	22.30	11.52	16.19	15.35	16.88	11.75
EV/EBIT Ratio	23.94	28.78	37.09	27.12	32.74	21.29
EV/FCF Ratio	-209.27	31423.90	-	41.99	-	-
Debt / Equity Ratio	0.00	0.00	-	0.00	0.00	-
Debt / EBITDA Ratio	0.13	0.06	-	0.02	0.05	-
Debt / FCF Ratio	-	176.56	-	0.07	-	-
Asset Turnover	0.15	0.15	0.17	0.21	0.23	0.28
Inventory Turnover	0.65	0.63	0.71	0.82	0.96	1.19
Quick Ratio	1.50	1.45	1.45	1.56	1.64	2.86
Current Ratio	3.43	3.39	3.40	3.61	3.72	5.10
Return on Equity (ROE)	2.21%	1.96%	3.01%	3.72%	3.75%	3.76%
Return on Assets (ROA)	1.39%	1.32%	1.53%	2.25%	1.85%	2.32%
Return on Capital (ROIC)	1.66%	1.58%	1.82%	2.67%	2.19%	2.74%
Return on Capital Employed (ROCE)	2.50%	2.40%	2.70%	4.00%	3.30%	4.00%
Earnings Yield	341.18%	2.61%	2.73%	3.08%	3.12%	3.58%
FCF Yield	-47.15%	0.00%	-0.06%	2.30%	-4.40%	-1.01%
Dividend Yield	66.66%	0.60%	1.25%	1.97%	4.15%	5.06%
Payout Ratio	3698.32%	41.72%	45.43%	74.15%	73.25%	22.11%
Buyback Yield / Dilution	-95.80%	-	-	-	-	-28.88%
Total Shareholder Return	-29.14%	0.60%	1.25%	1.97%	4.15%	-23.82%

Updated Dec 3, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.